SCHEMBL3670928

SCHEMBL3670928

CCN1CCC[C@H](Nc2ncc(C(N)=O)c3sc(-c4ccsc4)cc23)C1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 20/20 0.69
▸ KCNH2 Q12809 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3069698 0.81 CHEK1 (1.00) CHEK1KCNH2
SCHEMBL3082469 0.78 CHEK1 (0.79) CHEK1KCNH2
SCHEMBL4347178 0.78 CHEK1 (1.00) CHEK1KCNH2
SCHEMBL3064129 0.77 CHEK1 (0.79) CHEK1KCNH2
SCHEMBL3064124 0.77 CHEK1 (0.79) CHEK1KCNH2
SCHEMBL3064132 0.77 CHEK1 (0.79) CHEK1KCNH2
SCHEMBL27723937 0.75 CHEK1 (0.78) CHEK1KCNH2
SCHEMBL27723942 0.74 CHEK1 (0.74) CHEK1KCNH2
SCHEMBL27703359 0.73 CHEK1 (0.79) CHEK1KCNH2
SCHEMBL5811825 0.72 CHEK1 (0.61) CHEK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2144630-A2 CHK1 INHIBITORS WITH B CELL DEPLETING ANTIBODIES FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES AstraZeneca AB (SE) 2010-01-20 — — EP disclosed
WO-2008132500-A2 CHKL INHIBITORS WITH B CELL DEPLETING ANTIBODIES FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES ASTRAZENECA AB (SE) 2008-11-06 — — WO disclosed
Send feedback